Klebsiella pneumonia

Klebsiella pneumoniae (K. pneumoniae) is a highly prevalent and antibiotic-resistant bacterium, known for causing both community-acquired and hospital-associated infections, especially in immunocompromised patients. It can colonize various parts of the body, including the skin, pharynx, and gastrointestinal tract, leading to a variety of diseases such as bacteremia, pneumonia, urinary tract infections, bloodstream infections, and liver abscesses. 

Gram-negative bacteria, including Klebsiella pneumoniae, can produce narrow-spectrum antimicrobial proteins called bacteriocins (referred to as klebicins when produced by K. pneumoniae). Bacteriocins have emerged as a promising alternative to conventional antibiotics. Unlike broad-spectrum antibiotics, bacteriocins are highly specialized proteins that can recognize and eliminate species-specific pathogens without disrupting the delicate balance of the host microbiota.  

The Institute for Digestive Research is conducting comprehensive studies on this group of bacteriocin proteins, including characterizing the target bacterial species, assessing their impact on recipient outcomes, and exploring delivery strategies in both non-mammalian and mammalian animal models. 

Scroll to Top